Local company receives premarket clearance on wound care product

The Omeza Collagen Matrix is the company's first medical prescription product.

  • By Business Observer Staff
  • | 10:07 a.m. September 13, 2021
  • | 0 Free Articles Remaining!
Courtesy. Pictured is Omeza Founder and CEO Tom Gardner.
Courtesy. Pictured is Omeza Founder and CEO Tom Gardner.
  • Manatee-Sarasota
  • Share

SARASOTA — Omeza, a Sarasota-based skin science company, announced that its Omeza Collagen Matrix (OCM) product was cleared through the FDA 510(k) premarket notification process.  

The product is Omeza’s first medical prescription product.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • December 13, 2025
Report: Small business optimism up, but worries percolate
  • December 12, 2025
CEO of Bradenton EDC announces retirement
  • December 12, 2025
Manatee County to break ground on $40M veterans complex
  • December 12, 2025
Moez Limayem confirmed as USF’s new president

Sponsored Content